Lee Ainslie Wave Life Sciences Ltd. Call Options Transaction History
Maverick Capital LTD
- $5.07 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding WVE
# of Institutions
146Shares Held
93.9MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$269 Million1.37% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$99.7 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$91.2 Million35.47% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.36MShares$79.3 Million0.05% of portfolio
-
683 Capital Management, LLC New York, NY5.33MShares$78.8 Million2.42% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.28B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...